Amber Bio
Latest round
- Seed
Last raised
- Jun 2023
Total raised
- $26M
Investors
- 6
About Amber Bio
Based in California, US, and founded in 2021, Amber Bio, Inc is a biotechnology company that provides gene editing approaches for intractable diseases. The company was co-founded by Jacob Borrajo (CEO) and Basem Al-Shayeb. The company develops a gene editing system to treat undruggable diseases. In order to treat diseases that were previously untreatable, the company provides gene editing techniques using multi-kilobase RNA writing. This facilitates the creation of treatments for every distinct mutation in the patient population.
Who invested in Amber Bio
6 investors across 1 round
See all investors in Amber Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jun 7, 2023
Amount
$26M
Investors
Questions about Amber Bio
Who invested in Amber Bio?
Amber Bio has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amber Bio raised?
Amber Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Amber Bio last raise money?
Amber Bio's most recent round on record is a Seed, in Jun 2023.
What does Amber Bio do?
Based in California, US, and founded in 2021, Amber Bio, Inc is a biotechnology company that provides gene editing approaches for intractable diseases.
Where is Amber Bio headquartered?
Amber Bio is headquartered in San Francisco, US.
Which VCs invest in companies like Amber Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Amber Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Amber Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.